KKLIU Approval for Meta Ads in Malaysia

The short answer

KKLIU is the approval reference the Ministry of Health stamps on an advertisement it has cleared for a medicine or a health service. It is issued by the Medicine Advertisements Board, known in Malay as the Lembaga Iklan Ubat, under the Medicines (Advertisement and Sale) Act 1956 and the Medicine Advertisements Board Regulations 1976. If your Facebook or Instagram ad makes a medicinal or health-benefit claim to Malaysians, you generally need that approval before the ad runs, and the KKLIU number has to appear on the creative itself.

Two things trip advertisers up. First, having a product registration number is not the same as having advertising approval; those are separate processes run by different parts of the system. Second, clearing the Malaysian requirement does not clear Meta's own rules, which independently restrict how you can advertise drugs, supplements and weight-loss products. A compliant health ad in Malaysia has to pass both gates. This article walks through each one, flags where the public information is thin, and points you to the authorities to confirm the details that matter most.

What KKLIU actually is

The Medicine Advertisements Board is the body inside the Ministry of Health that vets advertising for medicines and health services. It was established under the Medicine Advertisements Board Regulations 1976 and operates under the Medicines (Advertisement and Sale) Act 1956, which is the governing law for how medicines and related health claims can be promoted to the public in Malaysia. When the Board approves an advertisement, it issues an approval number in the format "KKLIU serial number/year", for example KKLIU 0213/2013, and that number must be displayed on every published version of the ad.

You will see the acronym KKLIU expanded in various ways online, usually along the lines of a Ministry of Health approval for a medicine advertisement. We could not confirm the exact official expansion verbatim from a loaded Ministry page in preparing this guide, so we are treating the acronym as the approval reference itself rather than quoting a precise wording. What matters operationally is simpler: KKLIU is the marker that an ad has been through the Board and been cleared, and its absence on a health-claim ad is a red flag both to regulators and to platforms.

Approval attaches to a specific creative. The Board reviews the actual visuals and wording you submit, so the number it issues belongs to that exact advertisement. Change the images or rewrite the claims and the original approval may no longer cover you.

Registration and advertising approval are two different things

This is the single most common misunderstanding, so it is worth slowing down on. Product registration and advertising approval answer different questions and are handled by different parts of the Ministry.

Registration is about the product. Under the Drug Control Authority, administered through NPRA, a medicine or health supplement is assessed for quality, safety and efficacy and, if it passes, is given a registration number. Cosmetics take a lighter route: they are notified to NPRA rather than registered as medicines, under the Control of Drugs and Cosmetics Regulations 1984. Advertising approval is about a particular advertisement, and that is the Medicine Advertisements Board's job. An approved medicine advertisement must carry the product's Drug Control Authority registration number as well as its KKLIU approval number.

The practical takeaway: a registration number lets you sell, a KKLIU number lets you advertise a given creative. Holding the first does not grant the second. Plenty of Malaysian sellers assume that because their supplement is registered, any ad they write is automatically fine. It is not.

The two-track system also explains a pattern the authorities see often: a genuinely registered product paired with an advertisement the Board never reviewed. Registration status can be checked by consumers against the authority's records, but that only tells them the product is legitimate, not that the specific claims in your ad were cleared. So even a fully registered supplement can generate a non-compliant ad the moment its creative reaches beyond the approved wording. The safeguard is to treat every new claim as a fresh advertising question, separate from whatever registration you already hold.

Which ads need Medicine Advertisements Board approval

The rule of thumb is that advertising touching medicines or health services needs approval before it is published. Advertisements for medicines and pharmaceutical products, and for healthcare skills and services, require Board approval before they go public. Guidance on the rules is explicit that materials making health claims, even implied ones, that target Malaysian consumers need KKLIU approval, and that this includes social-media posts, in-store displays, packaging stickers and advertising across all media. A boosted Instagram post is an advertisement in exactly the same way a magazine page is.

The following matrix is a starting point, not a substitute for checking your specific product and claim with the authority.

It helps to be generous about what counts as an advertisement here. Because the guidance sweeps in health claims across all media, a boosted post, a paid influencer mention, an affiliate's caption and a live-selling session that promises a health benefit are all advertising in the eyes of the Board, not casual conversation. If you pay someone to put a medicinal or health-benefit claim in front of Malaysians, the approval obligation follows the claim rather than the format. That is easy to forget when the ad looks like an organic Reel or a candid testimonial video, yet the substance of the message is exactly what the rule cares about, and a native-looking post earns no special exemption.

Where the honest answer is "it depends on the exact wording," that is a signal to get the copy checked rather than to guess. Ads in health and beauty are among the most likely to be flagged, which is part of why our guide on why a Facebook ad gets rejected leans so heavily on claim discipline.

Medicines, supplements and cosmetics are not the same lane

Because the approval requirement hinges on the claim and the product category, mixing the two is where advertisers get into trouble. A cosmetic that is notified to NPRA cannot lawfully make medicinal or treatment claims; the moment it does, it is being advertised as a medicine, which would require a medicine registration and Board clearance. So a moisturiser can talk about hydration and radiance, but "clears eczema" or "treats acne" pushes it into medicine territory.

The claims also have to match the product's approved category and evidence. Claims are supposed to be substantiable against approved labelling or scientific evidence, not aspirational marketing language. A supplement registered on one basis cannot suddenly claim to do something outside that basis just because it sounds better in an ad.

A note on the registration-number formats: you will see references online to a "MAL" prefix for registered medicines and supplements and a "NOT" prefix for notified cosmetics. We saw those described in secondary summaries but could not confirm the precise digit-and-letter structure from a loaded NPRA page for this guide, so we are not stating the exact format as fact. If you need to verify a product's status or the correct number format, check directly with NPRA rather than relying on a marketing blog. The same discipline that keeps you inside halal ad creative rules applies here: match the claim to what the product is actually certified or registered to do.

What the KKLIU number looks like and where it goes

Once the Board approves an advertisement, the KKLIU number is not optional decoration. It must be displayed on every published version of that advertisement, and the format is "KKLIU serial number/year", such as KKLIU 0213/2013. On a static Facebook image or an Instagram Story, that means placing the number somewhere legible within the creative or the caption. On a video, it should be visible in-frame long enough to be read. The Ministry's own guidance on how to recognise an approved advertisement is worth reading precisely because consumers are told to look for that number, which means its absence is conspicuous.

Because the approval is tied to the specific creative, treat the number as belonging to that exact ad. If you redesign the visuals, swap the hero image, or reword the claim, the original approval may no longer apply, and running the changed ad under the old number is not a safe assumption. Build a habit of tracking which KKLIU number maps to which live creative, especially if you run several variations. That mapping also helps if an ad is questioned: you can show the exact approved version. Keeping research, creative variants and their approvals organised in one place, whether in a spreadsheet or a platform like AdPlay.ai, saves a scramble later.

Meta's rules stack on top of the local ones

Clearing the Malaysian side does not clear Meta. Its advertising standards apply globally and independently, and for health-related products they are strict. For prescription drugs, Meta requires prior written authorization and limits those ads to the United States, Canada and New Zealand. Malaysia is not on that list, so there is effectively no compliant path to advertise prescription drugs to Malaysians on Facebook or Instagram, regardless of any local approval. Over-the-counter medicines are treated more leniently: Meta allows them where they comply with applicable local laws and where the audience is aged 18 or over. For Malaysia, "applicable local laws" is exactly the Medicines (Advertisement and Sale) Act 1956 and the KKLIU requirement.

It is worth being concrete about the over-the-counter path, because that is where most Malaysian health advertisers actually operate. Meta permits OTC medicine ads only where they follow applicable local laws and target an audience aged 18 or over, so age-gating your targeting is not optional. Layer the local requirement on top and the checklist is clear: the product must be lawfully sold, any health claim must carry KKLIU approval, the number must sit on the creative, and the audience must exclude under-18s. Miss the age setting and Meta can reject the ad on its own terms even when your Malaysian paperwork is perfect, which is a common and easily avoided stumble.

It is important to be precise about who requires what. Meta's published policies do not mention Malaysia or KKLIU at all, and there is no known field in Ads Manager to enter a KKLIU number. The obligation to hold approval and display the number is a Malaysian legal one that you must satisfy as the advertiser; Meta simply enforces its own separate rules. So do not tell yourself that passing Meta's review means you are compliant locally, and do not assume local approval will stop Meta from rejecting an ad that breaks its health standards. If your ad does get held up on Meta's side, our guides on ads stuck in review and why ads get rejected explain how the platform's process works.

The before-and-after and body-image trap

One Meta rule catches Malaysian health, beauty and fitness advertisers again and again: the ban on before-and-after imagery in weight-loss ads. Meta's Health and Wellness standard prohibits weight-loss ads that show side-by-side before-and-after comparisons of using a product or a transformation, with fitness classes as a stated exception. It also prohibits content that implies negative self-perception or promotes an ideal body type, requires that any results shown reflect realistic time-to-results, and requires 18-plus targeting for both weight-loss and cosmetic-procedure ads.

That means the split-screen slimming ad, a staple of local supplement marketing, is likely to be rejected on Meta even if every Malaysian approval is in order. The two rule sets are additive, not interchangeable. The fix is not to fight the policy but to build creative that never relied on it: show the product and how it fits a routine, use testimonials that avoid shaming language, and be honest about timelines. Our breakdown of before-and-after ads and of social-proof ads covers formats that stay inside the rules while still doing the persuasive work. Weave the KKLIU number into that compliant creative and you have covered both gates at once.

The penalty for skipping approval

There is a real cost to advertising without approval. Contravening the advertising provisions of the Medicines (Advertisement and Sale) Act 1956 can carry a fine of up to RM3,000 per violation on a first conviction, and up to RM5,000, or imprisonment for up to two years, or both, on a subsequent conviction, under Section 5 of Act 290. The reported consequences also extend to product seizure and blacklisting. "Per violation" matters: a campaign with several non-compliant ads is not one problem but several.

Those amounts sit in Section 5 of the consolidated Act 290, and they are strikingly low by modern standards, which is one reason enforcement also leans on product seizure, blacklisting and platform action rather than the fine alone. One honest caveat: the figures reflect the Act as revised in 1983, and we could not confirm from a primary source whether they have since been amended upward, so if the exact number is material to a decision, check the current text of Act 290 or ask a licensed regulatory agent. What is not in doubt is the direction: running unapproved health ads exposes you to legal penalties on the Malaysian side and to rejection, removal and account action on Meta's side, which can escalate to a restricted or disabled account.

A practical sequence before you press publish

Putting it together, here is a sensible order of operations for a Malaysian health, supplement or skincare advertiser preparing a Meta campaign. This is a general workflow, not legal advice, and the specifics of your product may change it.

First, confirm the product's status with NPRA. Is it a registered medicine or supplement, or a notified cosmetic? That determines what claims are even on the table. Second, if the ad makes any medicinal or health-benefit claim, seek Medicine Advertisements Board approval for the exact creative before you run it, not after. Third, put the KKLIU number, and the product registration number where required, visibly on the creative. Fourth, run the creative against Meta's own rules: no banned before-and-after, no content implying negative self-perception, realistic timelines, 18-plus targeting for weight-loss and cosmetic-procedure ads, and no attempt to advertise prescription drugs to a Malaysian audience.

Approval covers a specific creative, so bake this sequence into your production process rather than treating it as a one-off. Every genuinely new variation may need its own clearance. Building your ad testing plan around approved creatives from the start, as our guide on running a Facebook ad describes, is far cheaper than pulling live ads after a rejection.

What we could not verify, and why that matters

Being straight about the gaps is part of doing this responsibly. Several figures that circulate widely for KKLIU could not be confirmed from a primary Ministry source while writing this guide, so we have left them out rather than dress up a guess as fact. The KKLIU approval's validity period, the turnaround time from submission to a decision, and any application fees vary between secondary sources: one says roughly a year of validity with issuance within a few working days of a complete application, another quotes several weeks of processing and a fee range. None came from an official Ministry of Health page, so we are not stating any specific validity, timeline or fee. When you plan a launch, ask the Pharmaceutical Services Programme directly so your timing is built on their numbers, not a blog's.

Likewise, the precise registration-number formats and the official expansion of the KKLIU acronym are things we saw only in secondary summaries and are not asserting as settled. The rules that are well supported are the ones this guide leans on: the Board's legal basis, the requirement to approve health-claim ads before publication including on social media, the mandatory display of the KKLIU number, the RM3,000 first-conviction and RM5,000 subsequent-conviction fines under Section 5 of Act 290, and Meta's drug and health standards. For anything beyond those, confirm with the Medicine Advertisements Board, NPRA or a licensed regulatory agent before you spend. Health advertising in Malaysia is one of the areas where a quick verification call is worth far more than the price of getting it wrong. This is educational content, not legal advice, and the governing law here is the Medicines (Advertisement and Sale) Act 1956, administered by the Ministry of Health.